nodes	percent_of_prediction	percent_of_DWPC	metapath
Isradipine—CACNA1S—pes—germ cell cancer	0.0961	0.216	CbGeAlD
Isradipine—CACNA1D—cochlea—germ cell cancer	0.0347	0.0779	CbGeAlD
Isradipine—CACNA1D—internal ear—germ cell cancer	0.0329	0.0739	CbGeAlD
Isradipine—CACNA1D—ear—germ cell cancer	0.0222	0.0498	CbGeAlD
Isradipine—CACNA2D2—neck—germ cell cancer	0.0117	0.0263	CbGeAlD
Isradipine—CACNA2D2—telencephalon—germ cell cancer	0.00795	0.0178	CbGeAlD
Isradipine—CYP3A4—urine—germ cell cancer	0.0069	0.0155	CbGeAlD
Isradipine—CACNB2—retina—germ cell cancer	0.00662	0.0148	CbGeAlD
Isradipine—CACNA2D2—pituitary gland—germ cell cancer	0.00647	0.0145	CbGeAlD
Isradipine—CACNA2D1—brainstem—germ cell cancer	0.00644	0.0145	CbGeAlD
Isradipine—CACNB2—telencephalon—germ cell cancer	0.00609	0.0137	CbGeAlD
Isradipine—CACNA2D2—adrenal gland—germ cell cancer	0.00578	0.013	CbGeAlD
Isradipine—CACNA2D2—midbrain—germ cell cancer	0.00571	0.0128	CbGeAlD
Isradipine—CACNA2D2—spinal cord—germ cell cancer	0.00557	0.0125	CbGeAlD
Isradipine—CACNA1H—gonad—germ cell cancer	0.00538	0.0121	CbGeAlD
Isradipine—CACNA1H—uterus—germ cell cancer	0.00534	0.012	CbGeAlD
Isradipine—CACNA1D—telencephalon—germ cell cancer	0.00532	0.0119	CbGeAlD
Isradipine—CACNA1H—pituitary gland—germ cell cancer	0.00525	0.0118	CbGeAlD
Isradipine—CACNA2D2—endocrine gland—germ cell cancer	0.00501	0.0112	CbGeAlD
Isradipine—CACNB2—pituitary gland—germ cell cancer	0.00496	0.0111	CbGeAlD
Isradipine—CACNA2D2—head—germ cell cancer	0.00495	0.0111	CbGeAlD
Isradipine—CACNA1C—telencephalon—germ cell cancer	0.00491	0.011	CbGeAlD
Isradipine—CACNA2D2—testis—germ cell cancer	0.00478	0.0107	CbGeAlD
Isradipine—CACNA1H—adrenal gland—germ cell cancer	0.00469	0.0105	CbGeAlD
Isradipine—CACNA1C—decidua—germ cell cancer	0.00466	0.0104	CbGeAlD
Isradipine—CACNB2—adrenal gland—germ cell cancer	0.00443	0.00993	CbGeAlD
Isradipine—CACNA2D2—cerebellum—germ cell cancer	0.00442	0.00991	CbGeAlD
Isradipine—CACNA1H—female gonad—germ cell cancer	0.00437	0.00981	CbGeAlD
Isradipine—CACNA1D—pituitary gland—germ cell cancer	0.00433	0.00972	CbGeAlD
Isradipine—CACNA2D1—adrenal gland—germ cell cancer	0.00416	0.00933	CbGeAlD
Isradipine—CACNA1H—endocrine gland—germ cell cancer	0.00407	0.00912	CbGeAlD
Isradipine—CACNA2D1—bone marrow—germ cell cancer	0.00402	0.00902	CbGeAlD
Isradipine—CACNA1C—pituitary gland—germ cell cancer	0.004	0.00897	CbGeAlD
Isradipine—CACNA1H—testis—germ cell cancer	0.00388	0.0087	CbGeAlD
Isradipine—CACNA2D1—female gonad—germ cell cancer	0.00388	0.0087	CbGeAlD
Isradipine—CACNA1D—adrenal gland—germ cell cancer	0.00387	0.00868	CbGeAlD
Isradipine—CACNB2—head—germ cell cancer	0.00379	0.0085	CbGeAlD
Isradipine—CACNB2—testis—germ cell cancer	0.00366	0.00821	CbGeAlD
Isradipine—CACNA2D1—endocrine gland—germ cell cancer	0.00361	0.00809	CbGeAlD
Isradipine—CACNA2D2—brain—germ cell cancer	0.00359	0.00805	CbGeAlD
Isradipine—CACNA1H—cerebellum—germ cell cancer	0.00358	0.00803	CbGeAlD
Isradipine—CACNA1C—adrenal gland—germ cell cancer	0.00357	0.00801	CbGeAlD
Isradipine—CACNA2D1—head—germ cell cancer	0.00356	0.00799	CbGeAlD
Isradipine—CACNA2D2—lymph node—germ cell cancer	0.00347	0.00777	CbGeAlD
Isradipine—CACNA2D1—testis—germ cell cancer	0.00344	0.00771	CbGeAlD
Isradipine—CACNB2—cerebellum—germ cell cancer	0.00338	0.00759	CbGeAlD
Isradipine—CACNA1D—endocrine gland—germ cell cancer	0.00336	0.00753	CbGeAlD
Isradipine—CACNA1D—head—germ cell cancer	0.00331	0.00743	CbGeAlD
Isradipine—CACNA1D—testis—germ cell cancer	0.0032	0.00718	CbGeAlD
Isradipine—CACNA2D1—cerebellum—germ cell cancer	0.00318	0.00713	CbGeAlD
Isradipine—CACNA1C—endocrine gland—germ cell cancer	0.0031	0.00695	CbGeAlD
Isradipine—CACNA1C—head—germ cell cancer	0.00306	0.00686	CbGeAlD
Isradipine—CACNA1D—cerebellum—germ cell cancer	0.00296	0.00663	CbGeAlD
Isradipine—CACNA1C—testis—germ cell cancer	0.00295	0.00663	CbGeAlD
Isradipine—CACNA1H—brain—germ cell cancer	0.00291	0.00653	CbGeAlD
Isradipine—CACNA1H—lymph node—germ cell cancer	0.00281	0.00631	CbGeAlD
Isradipine—CACNB2—brain—germ cell cancer	0.00275	0.00616	CbGeAlD
Isradipine—CACNA1C—cerebellum—germ cell cancer	0.00273	0.00612	CbGeAlD
Isradipine—CACNB2—lymph node—germ cell cancer	0.00265	0.00595	CbGeAlD
Isradipine—CACNA2D1—brain—germ cell cancer	0.00258	0.00579	CbGeAlD
Isradipine—CACNA2D1—lymph node—germ cell cancer	0.00249	0.00559	CbGeAlD
Isradipine—CACNA1D—brain—germ cell cancer	0.0024	0.00539	CbGeAlD
Isradipine—Connective tissue disorder—Ifosfamide—germ cell cancer	0.00237	0.00428	CcSEcCtD
Isradipine—Urethral disorder—Ifosfamide—germ cell cancer	0.00237	0.00427	CcSEcCtD
Isradipine—Thrombocytopenia—Vinblastine—germ cell cancer	0.00233	0.0042	CcSEcCtD
Isradipine—Visual impairment—Ifosfamide—germ cell cancer	0.00233	0.0042	CcSEcCtD
Isradipine—CACNA1D—lymph node—germ cell cancer	0.00232	0.0052	CbGeAlD
Isradipine—Acute coronary syndrome—Cisplatin—germ cell cancer	0.00229	0.00413	CcSEcCtD
Isradipine—Ill-defined disorder—Bleomycin—germ cell cancer	0.00228	0.00412	CcSEcCtD
Isradipine—Anaemia—Bleomycin—germ cell cancer	0.00227	0.0041	CcSEcCtD
Isradipine—Myocardial infarction—Cisplatin—germ cell cancer	0.00227	0.0041	CcSEcCtD
Isradipine—Eye disorder—Ifosfamide—germ cell cancer	0.00226	0.00407	CcSEcCtD
Isradipine—Flushing—Ifosfamide—germ cell cancer	0.00224	0.00405	CcSEcCtD
Isradipine—Cardiac disorder—Ifosfamide—germ cell cancer	0.00224	0.00405	CcSEcCtD
Isradipine—Malaise—Bleomycin—germ cell cancer	0.00222	0.004	CcSEcCtD
Isradipine—CACNA1C—brain—germ cell cancer	0.00222	0.00497	CbGeAlD
Isradipine—Leukopenia—Bleomycin—germ cell cancer	0.0022	0.00397	CcSEcCtD
Isradipine—Hepatobiliary disease—Cisplatin—germ cell cancer	0.00219	0.00396	CcSEcCtD
Isradipine—Angiopathy—Ifosfamide—germ cell cancer	0.00219	0.00395	CcSEcCtD
Isradipine—Immune system disorder—Ifosfamide—germ cell cancer	0.00218	0.00394	CcSEcCtD
Isradipine—Mediastinal disorder—Ifosfamide—germ cell cancer	0.00218	0.00393	CcSEcCtD
Isradipine—Cough—Bleomycin—germ cell cancer	0.00215	0.00387	CcSEcCtD
Isradipine—CACNA1C—lymph node—germ cell cancer	0.00214	0.0048	CbGeAlD
Isradipine—Paraesthesia—Vinblastine—germ cell cancer	0.00214	0.00385	CcSEcCtD
Isradipine—Ill-defined disorder—Dactinomycin—germ cell cancer	0.00213	0.00384	CcSEcCtD
Isradipine—Anaemia—Dactinomycin—germ cell cancer	0.00212	0.00383	CcSEcCtD
Isradipine—Bradycardia—Cisplatin—germ cell cancer	0.00212	0.00383	CcSEcCtD
Isradipine—Mental disorder—Ifosfamide—germ cell cancer	0.00212	0.00382	CcSEcCtD
Isradipine—Malnutrition—Ifosfamide—germ cell cancer	0.0021	0.00379	CcSEcCtD
Isradipine—Acute coronary syndrome—Etoposide—germ cell cancer	0.0021	0.00378	CcSEcCtD
Isradipine—Chest pain—Bleomycin—germ cell cancer	0.00209	0.00378	CcSEcCtD
Isradipine—Myocardial infarction—Etoposide—germ cell cancer	0.00208	0.00376	CcSEcCtD
Isradipine—Discomfort—Bleomycin—germ cell cancer	0.00207	0.00373	CcSEcCtD
Isradipine—Malaise—Dactinomycin—germ cell cancer	0.00207	0.00373	CcSEcCtD
Isradipine—Decreased appetite—Vinblastine—germ cell cancer	0.00207	0.00373	CcSEcCtD
Isradipine—Urine output increased—Methotrexate—germ cell cancer	0.00206	0.00371	CcSEcCtD
Isradipine—Urinary tract disorder—Cisplatin—germ cell cancer	0.00206	0.00371	CcSEcCtD
Isradipine—Leukopenia—Dactinomycin—germ cell cancer	0.00205	0.00371	CcSEcCtD
Isradipine—Connective tissue disorder—Cisplatin—germ cell cancer	0.00205	0.00369	CcSEcCtD
Isradipine—Urethral disorder—Cisplatin—germ cell cancer	0.00204	0.00368	CcSEcCtD
Isradipine—Gynaecomastia—Methotrexate—germ cell cancer	0.00204	0.00367	CcSEcCtD
Isradipine—Constipation—Vinblastine—germ cell cancer	0.00203	0.00367	CcSEcCtD
Isradipine—Hepatobiliary disease—Etoposide—germ cell cancer	0.00201	0.00363	CcSEcCtD
Isradipine—Oedema—Bleomycin—germ cell cancer	0.00201	0.00362	CcSEcCtD
Isradipine—Anaphylactic shock—Bleomycin—germ cell cancer	0.00201	0.00362	CcSEcCtD
Isradipine—Visual impairment—Cisplatin—germ cell cancer	0.00201	0.00362	CcSEcCtD
Isradipine—Vision blurred—Ifosfamide—germ cell cancer	0.00198	0.00358	CcSEcCtD
Isradipine—Thrombocytopenia—Bleomycin—germ cell cancer	0.00197	0.00355	CcSEcCtD
Isradipine—Feeling abnormal—Vinblastine—germ cell cancer	0.00196	0.00354	CcSEcCtD
Isradipine—Ill-defined disorder—Ifosfamide—germ cell cancer	0.00195	0.00352	CcSEcCtD
Isradipine—Eye disorder—Cisplatin—germ cell cancer	0.00195	0.00351	CcSEcCtD
Isradipine—Anaemia—Ifosfamide—germ cell cancer	0.00194	0.00351	CcSEcCtD
Isradipine—Flushing—Cisplatin—germ cell cancer	0.00193	0.00349	CcSEcCtD
Isradipine—Cardiac disorder—Cisplatin—germ cell cancer	0.00193	0.00349	CcSEcCtD
Isradipine—Discomfort—Dactinomycin—germ cell cancer	0.00193	0.00348	CcSEcCtD
Isradipine—Angioedema—Ifosfamide—germ cell cancer	0.00192	0.00347	CcSEcCtD
Isradipine—Hypoaesthesia—Etoposide—germ cell cancer	0.0019	0.00343	CcSEcCtD
Isradipine—Malaise—Ifosfamide—germ cell cancer	0.0019	0.00342	CcSEcCtD
Isradipine—Urinary tract disorder—Etoposide—germ cell cancer	0.00188	0.0034	CcSEcCtD
Isradipine—Leukopenia—Ifosfamide—germ cell cancer	0.00188	0.0034	CcSEcCtD
Isradipine—Polyuria—Methotrexate—germ cell cancer	0.00188	0.00339	CcSEcCtD
Isradipine—Immune system disorder—Cisplatin—germ cell cancer	0.00188	0.00339	CcSEcCtD
Isradipine—Mediastinal disorder—Cisplatin—germ cell cancer	0.00188	0.00339	CcSEcCtD
Isradipine—Hypotension—Bleomycin—germ cell cancer	0.00188	0.00339	CcSEcCtD
Isradipine—Oedema—Dactinomycin—germ cell cancer	0.00187	0.00338	CcSEcCtD
Isradipine—Urethral disorder—Etoposide—germ cell cancer	0.00187	0.00337	CcSEcCtD
Isradipine—Palpitations—Ifosfamide—germ cell cancer	0.00186	0.00335	CcSEcCtD
Isradipine—Cough—Ifosfamide—germ cell cancer	0.00184	0.00331	CcSEcCtD
Isradipine—Thrombocytopenia—Dactinomycin—germ cell cancer	0.00183	0.00331	CcSEcCtD
Isradipine—Musculoskeletal discomfort—Bleomycin—germ cell cancer	0.00183	0.0033	CcSEcCtD
Isradipine—Malnutrition—Cisplatin—germ cell cancer	0.00181	0.00327	CcSEcCtD
Isradipine—Paraesthesia—Bleomycin—germ cell cancer	0.0018	0.00325	CcSEcCtD
Isradipine—Dyspnoea—Bleomycin—germ cell cancer	0.00179	0.00323	CcSEcCtD
Isradipine—Arthralgia—Ifosfamide—germ cell cancer	0.00179	0.00323	CcSEcCtD
Isradipine—Chest pain—Ifosfamide—germ cell cancer	0.00179	0.00323	CcSEcCtD
Isradipine—Eye disorder—Etoposide—germ cell cancer	0.00178	0.00322	CcSEcCtD
Isradipine—Unspecified disorder of skin and subcutaneous tissue—Ifosfamide—germ cell cancer	0.00178	0.00321	CcSEcCtD
Isradipine—Flushing—Etoposide—germ cell cancer	0.00177	0.0032	CcSEcCtD
Isradipine—Cardiac disorder—Etoposide—germ cell cancer	0.00177	0.0032	CcSEcCtD
Isradipine—Discomfort—Ifosfamide—germ cell cancer	0.00177	0.00319	CcSEcCtD
Isradipine—Decreased appetite—Bleomycin—germ cell cancer	0.00175	0.00315	CcSEcCtD
Isradipine—Visual disturbance—Methotrexate—germ cell cancer	0.00174	0.00315	CcSEcCtD
Isradipine—Muscle spasms—Cisplatin—germ cell cancer	0.00174	0.00315	CcSEcCtD
Isradipine—Angiopathy—Etoposide—germ cell cancer	0.00173	0.00312	CcSEcCtD
Isradipine—Immune system disorder—Etoposide—germ cell cancer	0.00172	0.00311	CcSEcCtD
Isradipine—Mediastinal disorder—Etoposide—germ cell cancer	0.00172	0.0031	CcSEcCtD
Isradipine—Oedema—Ifosfamide—germ cell cancer	0.00172	0.0031	CcSEcCtD
Isradipine—Anaphylactic shock—Ifosfamide—germ cell cancer	0.00172	0.0031	CcSEcCtD
Isradipine—Vision blurred—Cisplatin—germ cell cancer	0.00171	0.00308	CcSEcCtD
Isradipine—Musculoskeletal discomfort—Dactinomycin—germ cell cancer	0.00171	0.00308	CcSEcCtD
Isradipine—Asthenia—Vinblastine—germ cell cancer	0.00171	0.00308	CcSEcCtD
Isradipine—Lethargy—Methotrexate—germ cell cancer	0.00169	0.00304	CcSEcCtD
Isradipine—Cerebrovascular accident—Methotrexate—germ cell cancer	0.00169	0.00304	CcSEcCtD
Isradipine—Nervous system disorder—Ifosfamide—germ cell cancer	0.00168	0.00304	CcSEcCtD
Isradipine—Ill-defined disorder—Cisplatin—germ cell cancer	0.00168	0.00304	CcSEcCtD
Isradipine—Thrombocytopenia—Ifosfamide—germ cell cancer	0.00168	0.00303	CcSEcCtD
Isradipine—Anaemia—Cisplatin—germ cell cancer	0.00168	0.00302	CcSEcCtD
Isradipine—Skin disorder—Ifosfamide—germ cell cancer	0.00167	0.00301	CcSEcCtD
Isradipine—Hyperhidrosis—Ifosfamide—germ cell cancer	0.00166	0.00299	CcSEcCtD
Isradipine—Feeling abnormal—Bleomycin—germ cell cancer	0.00165	0.00299	CcSEcCtD
Isradipine—Malaise—Cisplatin—germ cell cancer	0.00164	0.00295	CcSEcCtD
Isradipine—Decreased appetite—Dactinomycin—germ cell cancer	0.00163	0.00294	CcSEcCtD
Isradipine—Diarrhoea—Vinblastine—germ cell cancer	0.00163	0.00294	CcSEcCtD
Isradipine—Leukopenia—Cisplatin—germ cell cancer	0.00162	0.00293	CcSEcCtD
Isradipine—Fatigue—Dactinomycin—germ cell cancer	0.00161	0.00291	CcSEcCtD
Isradipine—Back pain—Etoposide—germ cell cancer	0.00161	0.0029	CcSEcCtD
Isradipine—Hypotension—Ifosfamide—germ cell cancer	0.0016	0.00289	CcSEcCtD
Isradipine—Muscle spasms—Etoposide—germ cell cancer	0.0016	0.00288	CcSEcCtD
Isradipine—Urticaria—Bleomycin—germ cell cancer	0.0016	0.00288	CcSEcCtD
Isradipine—Dizziness—Vinblastine—germ cell cancer	0.00157	0.00284	CcSEcCtD
Isradipine—Musculoskeletal discomfort—Ifosfamide—germ cell cancer	0.00156	0.00282	CcSEcCtD
Isradipine—Feeling abnormal—Dactinomycin—germ cell cancer	0.00154	0.00278	CcSEcCtD
Isradipine—Paraesthesia—Ifosfamide—germ cell cancer	0.00154	0.00278	CcSEcCtD
Isradipine—Ill-defined disorder—Etoposide—germ cell cancer	0.00154	0.00278	CcSEcCtD
Isradipine—Anxiety—Cisplatin—germ cell cancer	0.00154	0.00278	CcSEcCtD
Isradipine—Anaemia—Etoposide—germ cell cancer	0.00154	0.00277	CcSEcCtD
Isradipine—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—germ cell cancer	0.00153	0.00277	CcSEcCtD
Isradipine—Dyspnoea—Ifosfamide—germ cell cancer	0.00153	0.00276	CcSEcCtD
Isradipine—Somnolence—Ifosfamide—germ cell cancer	0.00153	0.00275	CcSEcCtD
Isradipine—Liver function test abnormal—Methotrexate—germ cell cancer	0.00153	0.00275	CcSEcCtD
Isradipine—Discomfort—Cisplatin—germ cell cancer	0.00153	0.00275	CcSEcCtD
Isradipine—Vomiting—Vinblastine—germ cell cancer	0.00151	0.00273	CcSEcCtD
Isradipine—Malaise—Etoposide—germ cell cancer	0.0015	0.0027	CcSEcCtD
Isradipine—Breast disorder—Methotrexate—germ cell cancer	0.00149	0.00269	CcSEcCtD
Isradipine—Decreased appetite—Ifosfamide—germ cell cancer	0.00149	0.00269	CcSEcCtD
Isradipine—Headache—Vinblastine—germ cell cancer	0.00149	0.00269	CcSEcCtD
Isradipine—Leukopenia—Etoposide—germ cell cancer	0.00149	0.00268	CcSEcCtD
Isradipine—Gastrointestinal disorder—Ifosfamide—germ cell cancer	0.00148	0.00267	CcSEcCtD
Isradipine—Fatigue—Ifosfamide—germ cell cancer	0.00148	0.00267	CcSEcCtD
Isradipine—Anaphylactic shock—Cisplatin—germ cell cancer	0.00148	0.00267	CcSEcCtD
Isradipine—Oedema—Cisplatin—germ cell cancer	0.00148	0.00267	CcSEcCtD
Isradipine—Constipation—Ifosfamide—germ cell cancer	0.00147	0.00265	CcSEcCtD
Isradipine—Loss of consciousness—Etoposide—germ cell cancer	0.00146	0.00263	CcSEcCtD
Isradipine—Nervous system disorder—Cisplatin—germ cell cancer	0.00145	0.00262	CcSEcCtD
Isradipine—Cough—Etoposide—germ cell cancer	0.00145	0.00262	CcSEcCtD
Isradipine—Thrombocytopenia—Cisplatin—germ cell cancer	0.00145	0.00261	CcSEcCtD
Isradipine—Tachycardia—Cisplatin—germ cell cancer	0.00144	0.00261	CcSEcCtD
Isradipine—Asthenia—Bleomycin—germ cell cancer	0.00144	0.0026	CcSEcCtD
Isradipine—Skin disorder—Cisplatin—germ cell cancer	0.00144	0.00259	CcSEcCtD
Isradipine—Hyperhidrosis—Cisplatin—germ cell cancer	0.00143	0.00258	CcSEcCtD
Isradipine—Pruritus—Bleomycin—germ cell cancer	0.00142	0.00256	CcSEcCtD
Isradipine—Feeling abnormal—Ifosfamide—germ cell cancer	0.00141	0.00255	CcSEcCtD
Isradipine—Chest pain—Etoposide—germ cell cancer	0.00141	0.00255	CcSEcCtD
Isradipine—Nausea—Vinblastine—germ cell cancer	0.00141	0.00255	CcSEcCtD
Isradipine—Unspecified disorder of skin and subcutaneous tissue—Etoposide—germ cell cancer	0.0014	0.00253	CcSEcCtD
Isradipine—Discomfort—Etoposide—germ cell cancer	0.0014	0.00252	CcSEcCtD
Isradipine—Hypotension—Cisplatin—germ cell cancer	0.00138	0.00249	CcSEcCtD
Isradipine—Abdominal discomfort—Methotrexate—germ cell cancer	0.00137	0.00247	CcSEcCtD
Isradipine—Urticaria—Ifosfamide—germ cell cancer	0.00136	0.00246	CcSEcCtD
Isradipine—Anaphylactic shock—Etoposide—germ cell cancer	0.00136	0.00245	CcSEcCtD
Isradipine—Musculoskeletal discomfort—Cisplatin—germ cell cancer	0.00135	0.00243	CcSEcCtD
Isradipine—Asthenia—Dactinomycin—germ cell cancer	0.00134	0.00242	CcSEcCtD
Isradipine—Paraesthesia—Cisplatin—germ cell cancer	0.00133	0.0024	CcSEcCtD
Isradipine—Thrombocytopenia—Etoposide—germ cell cancer	0.00133	0.00239	CcSEcCtD
Isradipine—Tachycardia—Etoposide—germ cell cancer	0.00132	0.00239	CcSEcCtD
Isradipine—Dyspnoea—Cisplatin—germ cell cancer	0.00132	0.00238	CcSEcCtD
Isradipine—Skin disorder—Etoposide—germ cell cancer	0.00132	0.00238	CcSEcCtD
Isradipine—Erectile dysfunction—Methotrexate—germ cell cancer	0.00132	0.00237	CcSEcCtD
Isradipine—Hyperhidrosis—Etoposide—germ cell cancer	0.00131	0.00236	CcSEcCtD
Isradipine—Photosensitivity reaction—Methotrexate—germ cell cancer	0.0013	0.00235	CcSEcCtD
Isradipine—Decreased appetite—Cisplatin—germ cell cancer	0.00129	0.00232	CcSEcCtD
Isradipine—Diarrhoea—Dactinomycin—germ cell cancer	0.00128	0.00231	CcSEcCtD
Isradipine—Gastrointestinal disorder—Cisplatin—germ cell cancer	0.00128	0.0023	CcSEcCtD
Isradipine—Vomiting—Bleomycin—germ cell cancer	0.00128	0.0023	CcSEcCtD
Isradipine—Drowsiness—Methotrexate—germ cell cancer	0.00127	0.0023	CcSEcCtD
Isradipine—Depression—Methotrexate—germ cell cancer	0.00127	0.00229	CcSEcCtD
Isradipine—Hypotension—Etoposide—germ cell cancer	0.00127	0.00229	CcSEcCtD
Isradipine—Rash—Bleomycin—germ cell cancer	0.00127	0.00228	CcSEcCtD
Isradipine—Dermatitis—Bleomycin—germ cell cancer	0.00127	0.00228	CcSEcCtD
Isradipine—Asthenia—Ifosfamide—germ cell cancer	0.00123	0.00222	CcSEcCtD
Isradipine—Feeling abnormal—Cisplatin—germ cell cancer	0.00122	0.0022	CcSEcCtD
Isradipine—Paraesthesia—Etoposide—germ cell cancer	0.00122	0.0022	CcSEcCtD
Isradipine—Pruritus—Ifosfamide—germ cell cancer	0.00121	0.00219	CcSEcCtD
Isradipine—Dyspnoea—Etoposide—germ cell cancer	0.00121	0.00218	CcSEcCtD
Isradipine—Somnolence—Etoposide—germ cell cancer	0.00121	0.00217	CcSEcCtD
Isradipine—Hepatobiliary disease—Methotrexate—germ cell cancer	0.0012	0.00217	CcSEcCtD
Isradipine—Nausea—Bleomycin—germ cell cancer	0.00119	0.00215	CcSEcCtD
Isradipine—Vomiting—Dactinomycin—germ cell cancer	0.00119	0.00215	CcSEcCtD
Isradipine—Rash—Dactinomycin—germ cell cancer	0.00118	0.00213	CcSEcCtD
Isradipine—Decreased appetite—Etoposide—germ cell cancer	0.00118	0.00213	CcSEcCtD
Isradipine—Diarrhoea—Ifosfamide—germ cell cancer	0.00117	0.00212	CcSEcCtD
Isradipine—Gastrointestinal disorder—Etoposide—germ cell cancer	0.00117	0.00211	CcSEcCtD
Isradipine—Fatigue—Etoposide—germ cell cancer	0.00117	0.00211	CcSEcCtD
Isradipine—Constipation—Etoposide—germ cell cancer	0.00116	0.00209	CcSEcCtD
Isradipine—CYP3A4—endocrine gland—germ cell cancer	0.00114	0.00257	CbGeAlD
Isradipine—Hepatitis—Methotrexate—germ cell cancer	0.00114	0.00206	CcSEcCtD
Isradipine—Dizziness—Ifosfamide—germ cell cancer	0.00114	0.00205	CcSEcCtD
Isradipine—Urinary tract disorder—Methotrexate—germ cell cancer	0.00113	0.00204	CcSEcCtD
Isradipine—Urethral disorder—Methotrexate—germ cell cancer	0.00112	0.00202	CcSEcCtD
Isradipine—Feeling abnormal—Etoposide—germ cell cancer	0.00112	0.00202	CcSEcCtD
Isradipine—Nausea—Dactinomycin—germ cell cancer	0.00111	0.00201	CcSEcCtD
Isradipine—Visual impairment—Methotrexate—germ cell cancer	0.0011	0.00199	CcSEcCtD
Isradipine—Vomiting—Ifosfamide—germ cell cancer	0.00109	0.00197	CcSEcCtD
Isradipine—Rash—Ifosfamide—germ cell cancer	0.00108	0.00195	CcSEcCtD
Isradipine—Dermatitis—Ifosfamide—germ cell cancer	0.00108	0.00195	CcSEcCtD
Isradipine—Urticaria—Etoposide—germ cell cancer	0.00108	0.00194	CcSEcCtD
Isradipine—Eye disorder—Methotrexate—germ cell cancer	0.00107	0.00193	CcSEcCtD
Isradipine—Asthenia—Cisplatin—germ cell cancer	0.00106	0.00192	CcSEcCtD
Isradipine—Cardiac disorder—Methotrexate—germ cell cancer	0.00106	0.00191	CcSEcCtD
Isradipine—Angiopathy—Methotrexate—germ cell cancer	0.00104	0.00187	CcSEcCtD
Isradipine—Immune system disorder—Methotrexate—germ cell cancer	0.00103	0.00186	CcSEcCtD
Isradipine—Mediastinal disorder—Methotrexate—germ cell cancer	0.00103	0.00186	CcSEcCtD
Isradipine—Nausea—Ifosfamide—germ cell cancer	0.00102	0.00184	CcSEcCtD
Isradipine—Diarrhoea—Cisplatin—germ cell cancer	0.00101	0.00183	CcSEcCtD
Isradipine—Mental disorder—Methotrexate—germ cell cancer	0.001	0.00181	CcSEcCtD
Isradipine—Malnutrition—Methotrexate—germ cell cancer	0.000995	0.0018	CcSEcCtD
Isradipine—Asthenia—Etoposide—germ cell cancer	0.000973	0.00175	CcSEcCtD
Isradipine—Back pain—Methotrexate—germ cell cancer	0.000962	0.00174	CcSEcCtD
Isradipine—Pruritus—Etoposide—germ cell cancer	0.000959	0.00173	CcSEcCtD
Isradipine—Vomiting—Cisplatin—germ cell cancer	0.000941	0.0017	CcSEcCtD
Isradipine—Vision blurred—Methotrexate—germ cell cancer	0.000938	0.00169	CcSEcCtD
Isradipine—Rash—Cisplatin—germ cell cancer	0.000933	0.00168	CcSEcCtD
Isradipine—Dermatitis—Cisplatin—germ cell cancer	0.000932	0.00168	CcSEcCtD
Isradipine—Diarrhoea—Etoposide—germ cell cancer	0.000928	0.00167	CcSEcCtD
Isradipine—Ill-defined disorder—Methotrexate—germ cell cancer	0.000923	0.00167	CcSEcCtD
Isradipine—Anaemia—Methotrexate—germ cell cancer	0.00092	0.00166	CcSEcCtD
Isradipine—Malaise—Methotrexate—germ cell cancer	0.000897	0.00162	CcSEcCtD
Isradipine—Dizziness—Etoposide—germ cell cancer	0.000896	0.00162	CcSEcCtD
Isradipine—Leukopenia—Methotrexate—germ cell cancer	0.000891	0.00161	CcSEcCtD
Isradipine—Nausea—Cisplatin—germ cell cancer	0.000879	0.00159	CcSEcCtD
Isradipine—Cough—Methotrexate—germ cell cancer	0.000868	0.00157	CcSEcCtD
Isradipine—Vomiting—Etoposide—germ cell cancer	0.000862	0.00156	CcSEcCtD
Isradipine—Rash—Etoposide—germ cell cancer	0.000855	0.00154	CcSEcCtD
Isradipine—Dermatitis—Etoposide—germ cell cancer	0.000854	0.00154	CcSEcCtD
Isradipine—Headache—Etoposide—germ cell cancer	0.000849	0.00153	CcSEcCtD
Isradipine—Arthralgia—Methotrexate—germ cell cancer	0.000847	0.00153	CcSEcCtD
Isradipine—Chest pain—Methotrexate—germ cell cancer	0.000847	0.00153	CcSEcCtD
Isradipine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—germ cell cancer	0.000841	0.00152	CcSEcCtD
Isradipine—Discomfort—Methotrexate—germ cell cancer	0.000837	0.00151	CcSEcCtD
Isradipine—Anaphylactic shock—Methotrexate—germ cell cancer	0.000812	0.00147	CcSEcCtD
Isradipine—Nausea—Etoposide—germ cell cancer	0.000805	0.00145	CcSEcCtD
Isradipine—Nervous system disorder—Methotrexate—germ cell cancer	0.000796	0.00144	CcSEcCtD
Isradipine—Thrombocytopenia—Methotrexate—germ cell cancer	0.000795	0.00143	CcSEcCtD
Isradipine—Skin disorder—Methotrexate—germ cell cancer	0.000789	0.00142	CcSEcCtD
Isradipine—Hyperhidrosis—Methotrexate—germ cell cancer	0.000785	0.00142	CcSEcCtD
Isradipine—Hypotension—Methotrexate—germ cell cancer	0.000759	0.00137	CcSEcCtD
Isradipine—Musculoskeletal discomfort—Methotrexate—germ cell cancer	0.00074	0.00133	CcSEcCtD
Isradipine—Insomnia—Methotrexate—germ cell cancer	0.000734	0.00133	CcSEcCtD
Isradipine—Paraesthesia—Methotrexate—germ cell cancer	0.000729	0.00132	CcSEcCtD
Isradipine—Dyspnoea—Methotrexate—germ cell cancer	0.000724	0.00131	CcSEcCtD
Isradipine—Somnolence—Methotrexate—germ cell cancer	0.000722	0.0013	CcSEcCtD
Isradipine—Dyspepsia—Methotrexate—germ cell cancer	0.000715	0.00129	CcSEcCtD
Isradipine—Decreased appetite—Methotrexate—germ cell cancer	0.000706	0.00127	CcSEcCtD
Isradipine—Gastrointestinal disorder—Methotrexate—germ cell cancer	0.000701	0.00126	CcSEcCtD
Isradipine—Fatigue—Methotrexate—germ cell cancer	0.0007	0.00126	CcSEcCtD
Isradipine—Feeling abnormal—Methotrexate—germ cell cancer	0.000669	0.00121	CcSEcCtD
Isradipine—Urticaria—Methotrexate—germ cell cancer	0.000645	0.00116	CcSEcCtD
Isradipine—Asthenia—Methotrexate—germ cell cancer	0.000583	0.00105	CcSEcCtD
Isradipine—Pruritus—Methotrexate—germ cell cancer	0.000574	0.00104	CcSEcCtD
Isradipine—Diarrhoea—Methotrexate—germ cell cancer	0.000556	0.001	CcSEcCtD
Isradipine—Dizziness—Methotrexate—germ cell cancer	0.000537	0.000969	CcSEcCtD
Isradipine—Vomiting—Methotrexate—germ cell cancer	0.000516	0.000931	CcSEcCtD
Isradipine—Rash—Methotrexate—germ cell cancer	0.000512	0.000924	CcSEcCtD
Isradipine—Dermatitis—Methotrexate—germ cell cancer	0.000511	0.000923	CcSEcCtD
Isradipine—Headache—Methotrexate—germ cell cancer	0.000509	0.000918	CcSEcCtD
Isradipine—Nausea—Methotrexate—germ cell cancer	0.000482	0.00087	CcSEcCtD
